All research
Semaglutide 2026-10-27 PubMed

Semaglutide in Patients with Obesity and Psoriasis: Insights from an 18-Month Real-World Experience.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


Source: pubmed:42941529 · Ingested Oct 27, 2026